Henry Schein (NASDAQ:HSIC) Sets New 12-Month High – Should You Buy?

Shares of Henry Schein, Inc. (NASDAQ:HSIC) hit a new 52-week high during trading on Thursday . The company traded as high as $82.73 and last traded at $82.5250, with a volume of 82315 shares trading hands. The stock had previously closed at $81.69.

Wall Street Analyst Weigh In

Several analysts recently issued reports on HSIC shares. Wells Fargo & Company increased their price target on Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a report on Wednesday, November 5th. Wall Street Zen raised Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. JPMorgan Chase & Co. increased their target price on Henry Schein from $76.00 to $78.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Barrington Research set a $79.00 price target on Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday, November 5th. Finally, Mizuho set a $81.00 price target on Henry Schein and gave the stock a “neutral” rating in a report on Tuesday, January 20th. Five analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $76.42.

Henry Schein Price Performance

The business has a fifty day moving average of $77.09 and a 200 day moving average of $71.28. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.40 and a quick ratio of 0.79. The stock has a market cap of $9.20 billion, a PE ratio of 24.74, a P/E/G ratio of 2.33 and a beta of 0.88.

Institutional Investors Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently modified their holdings of the stock. CYBER HORNET ETFs LLC acquired a new position in Henry Schein in the second quarter worth about $25,000. MUFG Securities EMEA plc bought a new position in Henry Schein during the 2nd quarter worth approximately $27,000. Flagship Harbor Advisors LLC bought a new position in Henry Schein during the 4th quarter worth approximately $30,000. Federated Hermes Inc. acquired a new position in shares of Henry Schein in the 4th quarter worth approximately $32,000. Finally, Los Angeles Capital Management LLC bought a new stake in shares of Henry Schein in the 4th quarter valued at approximately $37,000. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.